SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Investor presentation

29 Aug 2019 07:00

RNS Number : 4568K
Collagen Solutions PLC
29 August 2019
 

29 August 2019

Collagen Solutions plc

("Collagen Solutions" or the "Company")

 

ShareSoc Growth Company Seminar

 

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces will be presenting at the ShareSoc Growth Company Seminar in London on Wednesday, 11 September 2019.

 

Jamal Rushdy, CEO, will provide an update regarding progress highlighted during the recent Annual General Meeting, and the Company's prospects for growth.

 

The event will take place at the Offices of Link Asset Services, 65 Gresham Street, London EC2V 7NQ. Presentations will start at 5.30pm.

 

Further details of the event, along with a registration form, are available at:

https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-london-11-september-2019/ 

 

 

Collagen Solutions Plc

 

Jamal Rushdy, CEO 

Via Walbrook

Hilary Spence, CFO

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or collagen@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

 

 

 

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, tissue engineering, and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

 

For more information go to: www.collagensolutions.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFMGZRDRMGLZM

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS